We Care Your any
IT Solution

Mumbai, Jun 11 (PTI) The revenue of listed auto ancillary companies grew at a compound annual growth rate (CAGR) of 11 per cent during FY16-26, according to a report by Equirus Securities.

Sectoral revenues during the period rose nearly three-fold to about Rs 5 lakh crore during the period, according to the report.

It noted that exports have more than tripled over the past decade and have emerged as an important contributor to industry growth alongside rising vehicle content and premiumisation trends.

The sector entered FY27 with its strongest balance sheet position in a decade, it said, adding net debt-to-EBITDA improved to 0.18 times in FY26 from 0.49 times in FY22, aided by stronger cash flows, lower leverage and better working capital management.

The report, titled "Ten Years of Growth, Three Lessons and Where to Look Next", which was released recently, analyses the performance of 52 listed auto ancillary companies and outlines key themes expected to shape the sector's growth trajectory over FY27-30.

According to the report, 28 of the 52 companies under its coverage outperformed the sector's average revenue growth, while the performance varied widely across companies and segments despite the sector's overall growth.

The Equirus report also said these companies are expected to deliver a CAGR of 21 per cent in profit after tax (PAT) during FY26-28.

Among segments, body and glass was identified as one of the most attractive opportunities, with an estimated 30 per cent PAT CAGR over the period, it said.

The report identified diversification as one of the most important drivers of long-term growth. PTI IAS TRB

TRB

New Delhi, Jun 11 (PTI) MakeMyTrip on Thursday said it has launched early check-in and late check-out feature on its app, which can be availed by paying extra charges for hotel bookings by users.

As per the app, such bookings are available at extra charges across over 10,000 hotels, villas and homestays in India and over 1,000 properties across 20 international destinations.

"With 53 per cent of domestic travellers arriving before 9 AM and 54 per departing after 3 PM, the feature lets travellers confirm an early or late room slot at the time of booking. Travellers can now confirm an early or late room slot, in three, six, or nine-hour windows, at the time of booking," the company said.

According to Abhishek Logani, Chief Business Officer, Hotels, MakeMyTrip, the criteria travellers use to choose stays are evolving.

"Price and location remain important, but flexibility and confirmed access are also becoming an active part of the booking decision. Partners have recognised this shift: early-morning and late-evening inventory that previously went unmonetized now has a structured, revenue-generating use," he said. PTI RSN ANU

ANU

New Delhi, Jun 11 (PTI) Niti Aayog's 11th Governing Council meeting, chaired by Prime Minister Narendra Modi, began here on Thursday to deliberate on the government's approach for inclusive human development with the goal to attain the vision of Viksit Bharat by 2047.

"Chairing the 11th meeting of the Governing Council of NITI Aayog," PM Modi said in a social media post.

"Guided by the spirit of cooperative federalism, we are working together to accelerate India's development journey. The collective efforts of the Centre and States will play a pivotal role in realising our shared vision of Viksit Bharat," he added.

The Council will take up the 'Inclusive Human Development Framework', anchored around four core pillars -- foundational human capital and future-ready skills; productive employment, entrepreneurship and decentralised growth; health, nutrition and wellbeing; and equity and dignity for all, an official statement had said.

Measures to promote entrepreneurship, enhance skilling, and create sustainable employment opportunities across the country will also be discussed, it had said.

The governing council will also focus on the recommendations of the 5th National Conference of Chief Secretaries held during December 26-28, 2025.

Generally, the meeting of the entire council happens every year. Last year, it was held on May 24. PTI BKS TRB

Bangalore, 11th June 2026: Group Pharmaceuticals, a trusted name in the oral healthcare industry with over 45 years of expertise, recently announced the launch of Abledent in Bangalore. The launch event brought together healthcare professionals, caregivers, and industry stakeholders, underscoring the urgent need for more inclusive and patient-centric oral care solutions in India. In India, the need for assisted daily care, including oral hygiene, is rapidly growing across age groups. While 1 in every 20 elderly individuals live with some form of disability and nearly 40% of those aged 60+ face functional or health-related limitations, children and adults with disabilities, neurodivergent individuals, and those with special healthcare needs along with the caregivers who support them continue to face significant barriers to safe and accessible oral care. Despite this growing need, access to specialised and user-friendly oral care solutions tailored for assisted care remains limited in the country. Abledent has been developed with a clear purpose: to make daily oral hygiene safer, simpler, and more accessible for children and adults with disabilities, neurodivergent individuals, the elderly, hospitalised patients, individuals with temporary or permanent mobility challenges, and those dependent on caregivers.

Developed through extensive clinical insight and real-world research by Group Pharmaceuticals, Abledent offers safe if swallowed, non-foaming toothpastes for those unable to rinse or spit; fluoride-free and remineralising formulations for sensitive and medically vulnerable users; mouthwashes for enhanced enamel protection; and no-rinse oral care wipes for hospitalised and dependent care settings. The range also features inclusive packaging such as easy-open caps and braille and is built to overcome practical challenges including gag reflex, sensory sensitivities, mobility limitations, and caregiver-assisted routines - gaps long ignored by conventional oral care.

Speaking about the launch, Mr. Nikhil Kaushik, CEO- Group Pharmaceuticals said, “Healthy smiles are a birthright-not a privilege. With Abledent, we are addressing a critical gap in oral care by creating solutions that are not only clinically relevant but also empathetic to the real-world challenges faced by individuals with disabilities, children with special needs, patients and caregivers. For far too long, people with special oral care needs have had to adapt to products that were never designed for them. Abledent changes that by putting their dignity, comfort, and independence at the center of innovation.”

India’s oral care market has long overlooked the needs of dependent and special-care populations. The initiative is further strengthened by the Able Smile Community, an effort to build awareness, share resources, and create a supportive ecosystem for caregivers and individuals navigating assisted oral care. With this launch, Group Pharmaceuticals aims to introduce a new category of oral care in India, and spark greater awareness and conversation around inclusive healthcare, where accessibility and dignity are built into everyday solutions.

About Abledent

Guided by its philosophy, ‘Enabling Healthy Smiles for Everyone,’ Abledent is an inclusive oral care range by Group Pharmaceuticals designed for individuals with assisted and adaptive oral hygiene needs. Built on the promise of ‘More Easy. More Effective. More Able.’, the range combines clinical innovation with real-world usability to deliver safer, simpler, and more accessible oral care solutions for people across different life stages and health conditions.

About Group Pharmaceuticals Ltd

Founded in 1980 and is one of India’s leading oral care companies, driven by the belief that Healthy Smiles Matter. The company is widely recognised for launching many pioneering oral care products in India, including Potassium Nitrate Toothpaste Bioactive glass Technologies. Its brands Shy NM, Omnident, Pediflor, Elsenz among others are trusted by dental professionals and consumers. Its research-led innovations are developed in collaboration with globally reputed institutions including Queen Mary University of London, Columbia University, and JSS Academy of Higher Education & Research. Through science-backed innovation and a strong commitment to preventive oral healthcare, Group Pharmaceuticals continues to strengthen its position as a trusted name in India’s oral care landscape.

(Disclaimer: The above press release comes to you under an arrangement with NRDPL and PTI takes no editorial responsibility for the same.). PTI PWR PWR